Active Ingredient History
Senicapoc (ICA-17043) is a Gardos channel blocker. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Alzheimer Disease (Phase 2)
Anemia, Hemolytic (Phase 3)
Anemia, Sickle Cell (Phase 3)
Asthma (Phase 2)
Asthma, Exercise-Induced (Phase 2)
Cognitive Dysfunction (Phase 2)
COVID-19 (Phase 2)
Respiratory Distress Syndrome (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue